Top Stories: Elevance finalizes BioPlus acquisition; Deidentifying wearable data not enough to protect privacy

Photo: Mikolette/Getty Images

Another insurer has finalized a large acquisition. Who's the buyer, and what did it get? We'll touch on that and other topics in this week's Top Stories, including the privacy of data on wearable devices, and an opportunity for doctors to weigh in on AI-powered product development.

For more news and features from Jeff Lagasse, visit Healthcare Finance News.

In this episode:

• Elevance Health acquires specialty pharmacy company BioPlus
• Study: Deidentifying wearable data may not be enough to protect privacy
• DocsGPT in beta targets physician burnout

Talking points:

• Elevance anticipates the acquisition will help it meet the specialty drug needs of clients and customers with a more whole-health focused approach.
• This will be supported by programs across Elevance Health and Carelon, Elevance's healthcare services brand.
• Deidentifying data from wearable devices may not be enough to protect users' privacy, according to a review of studies published in the Lancet Digital Health.
• The online DocsGPT, which was developed using OpenAI's ChatGPT and trained on healthcare-specific prose, offers doctors a chance to test and weigh in on AI-powered product development.

Twitter: @JELagasse
Email the writer: Jeff.Lagasse@himssmedia.com